| scholarly article | Q13442814 |
| P2093 | author name string | Afroz S Mohammad | |
| Chris E Adkins | |||
| Paul R Lockman | |||
| Neal Shah | |||
| Emma L Dolan | |||
| Tori B Terrell-Hall | |||
| Jessica Griffith | |||
| Emily Sechrest | |||
| P2860 | cites work | Physicochemical and pharmacokinetic parameters of seven lipophilic chlorambucil esters designed for brain penetration | Q59606560 |
| Nontransgenic models of breast cancer | Q24800700 | ||
| Molecular determinants of blood-brain barrier permeation | Q26797482 | ||
| Gliomas and the vascular fragility of the blood brain barrier | Q28081953 | ||
| Structure and function of the blood-brain barrier | Q29615699 | ||
| The blood-brain barrier/neurovascular unit in health and disease | Q29616335 | ||
| Intracranial metastases: spectrum of MR imaging findings | Q30574051 | ||
| Brain metastases from breast cancer: lessons from experimental magnetic resonance imaging studies and clinical implications. | Q30708273 | ||
| Brain metastases of breast cancer. | Q31111302 | ||
| Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain | Q33283845 | ||
| Imagable 4T1 model for the study of late stage breast cancer | Q33358981 | ||
| Characteristics of compounds that cross the blood-brain barrier | Q33469828 | ||
| Advances in imaging low-grade gliomas | Q33526612 | ||
| Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study | Q34032708 | ||
| Vascular structures in brain tumors | Q34045197 | ||
| Relationship of octanol/water partition coefficient and molecular weight to rat brain capillary permeability | Q34057451 | ||
| The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption | Q34195312 | ||
| Breast tumor cell lines from pleural effusions | Q34209613 | ||
| The blood-brain and blood-tumor barriers: a review of strategies for increasing drug delivery | Q34218914 | ||
| CT and MRI of brain tumors. | Q34278399 | ||
| Ultrastructural pathology of endothelial tight junctions in human brain oedema | Q34330639 | ||
| Heterogeneous Blood–Tumor Barrier Permeability Determines Drug Efficacy in Experimental Brain Metastases of Breast Cancer | Q34393640 | ||
| Molecular characterisation of cell line models for triple-negative breast cancers | Q34476551 | ||
| Drug resistance in epilepsy: the role of the blood-brain barrier | Q34624873 | ||
| Increased permeability of the blood-brain barrier to chemotherapy in metastatic brain tumors: establishing a treatment paradigm | Q34632917 | ||
| Inflammatory breast cancer (IBC): clues for targeted therapies | Q34754098 | ||
| Blood-brain barrier breakdown in septic encephalopathy and brain tumours | Q34774036 | ||
| Low-grade gliomas and leptomeningeal dissemination: a poorly understood phenomenon | Q35102220 | ||
| Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy | Q35804288 | ||
| NKTR-102 Efficacy versus irinotecan in a mouse model of brain metastases of breast cancer | Q35805489 | ||
| Molecular mechanisms of brain tumor edema | Q35961516 | ||
| In Vivo Magnetic Resonance Imaging for Investigating the Development and Distribution of Experimental Brain Metastases due to Breast Cancer | Q36061810 | ||
| Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer. | Q36371783 | ||
| Characterization of the blood-brain barrier of metastatic and primary malignant neoplasms. | Q36560327 | ||
| Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis | Q37360238 | ||
| Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas | Q37480527 | ||
| Pericytes and vessel maturation during tumor angiogenesis and metastasis | Q37764322 | ||
| ABC transporters and cytochromes P450 in the human central nervous system: influence on brain pharmacokinetics and contribution to neurodegenerative disorders | Q37789041 | ||
| Studies of human breast cancer metastasis using nude mice | Q37912948 | ||
| Neurovascular unit: a focus on pericytes | Q37988811 | ||
| Tight junctions at the blood brain barrier: physiological architecture and disease-associated dysregulation | Q38058856 | ||
| Blood-brain barrier structure and function and the challenges for CNS drug delivery | Q38100970 | ||
| CNS metastases in breast cancer: old challenge, new frontiers | Q38168168 | ||
| Novel insights into the development and maintenance of the blood-brain barrier | Q38192912 | ||
| Gliovascular and cytokine interactions modulate brain endothelial barrier in vitro | Q40064513 | ||
| Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. | Q40474432 | ||
| Ultrastructure of capillary walls in human brain tumors | Q42493945 | ||
| The role of eNOS in vascular permeability in ENU-induced gliomas | Q43265274 | ||
| The Brain Microenvironment and Cancer Metastasis | Q43969265 | ||
| Optimal visualization of multiple brain metastases for gamma knife radiosurgery | Q46085756 | ||
| In vivo MRI of cancer cell fate at the single-cell level in a mouse model of breast cancer metastasis to the brain | Q48401147 | ||
| Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow | Q48413486 | ||
| Side by side comparison between dynamic versus static models of blood-brain barrier in vitro: a permeability study | Q48466858 | ||
| The Susceptibility of Cerebral Endothelial Cells to Astroglial Induction of Blood-Brain Barrier Enzymes Depends on Their Proliferative State | Q48620210 | ||
| In vivo characterization of changing blood-tumor barrier permeability in a mouse model of breast cancer metastasis: a complementary magnetic resonance imaging approach. | Q49013289 | ||
| Drug transport across the blood-brain barrier | Q57677287 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 373-383 | |
| P577 | publication date | 2016-03-05 | |
| P1433 | published in | Clinical & Experimental Metastasis | Q13470030 |
| P1476 | title | Characterization of passive permeability at the blood-tumor barrier in five preclinical models of brain metastases of breast cancer | |
| P478 | volume | 33 |
| Q38652516 | A mouse Model of Focal Vascular Injury Induces Astrocyte Reactivity, Tau Oligomers, and Aberrant Behavior. |
| Q39016244 | Advances in decoding breast cancer brain metastasis |
| Q47573654 | Drug delivery to melanoma brain metastases: Can current challenges lead to new opportunities? |
| Q91704255 | Drug resistance occurred in a newly characterized preclinical model of lung cancer brain metastasis |
| Q47839509 | Efficacy of T-DM1 for leptomeningeal and brain metastases in a HER2 positive metastatic breast cancer patient: new directions for systemic therapy - a case report and literature review |
| Q38953017 | Embracing rejection: Immunologic trends in brain metastasis |
| Q91796711 | Flaxseed Lignans as Important Dietary Polyphenols for Cancer Prevention and Treatment: Chemistry, Pharmacokinetics, and Molecular Targets |
| Q48108646 | Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases |
| Q98938406 | HER2-positive breast cancer brain metastasis: A new and exciting landscape |
| Q58698483 | Heterogeneous distribution of trastuzumab in HER2-positive xenografts and metastases: role of the tumor microenvironment |
| Q45048012 | Identification of Novel Agents for the Treatment of Brain Metastases of Breast Cancer |
| Q92675544 | Improving CNS Delivery to Brain Metastases by Blood-Tumor Barrier Disruption |
| Q38720211 | In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer |
| Q54118354 | Investigational chemotherapy and novel pharmacokinetic mechanisms for the treatment of breast cancer brain metastases. |
| Q47549277 | Liposomal Irinotecan Accumulates in Metastatic Lesions, Crosses the Blood-Tumor Barrier (BTB), and Prolongs Survival in an Experimental Model of Brain Metastases of Triple Negative Breast Cancer |
| Q39330269 | Nanotherapeutic systems for local treatment of brain tumors |
| Q37602559 | Permeability across a novel microfluidic blood-tumor barrier model |
| Q59790152 | Permeability changes and effect of chemotherapy in brain adjacent to tumor in an experimental model of metastatic brain tumor from breast cancer |
| Q45046519 | Quantitative Fluorescence Microscopy Measures Vascular Pore Size in Primary and Metastatic Brain Tumors |
| Q52673453 | The Evolving Landscape of Brain Metastasis. |
Search more.